Moderna
MRNA
#74
Rank
$173.62 B
Marketcap
🇺🇸 USA
Country
$430.14
Share price
-5.38%
Change (1 day)
519.17%
Change (1 year)
Categories
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Revenue for Moderna (MRNA)
Revenue in 2021 (TTM): $2.73 B
According to Moderna 's latest financial reports the company's current revenue (TTM) is $2.73 B. In 2020 the company made a revenue of $0.80 B an increase over the years 2019 revenue that were of $0.06 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expences are substracted.
Revenue history for Moderna from 2018 to 2021
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $2.73 B | 240.06% |
| 2020 | $0.80 B | 1234.34% |
| 2019 | $0.06 B | -55.42% |
| 2018 | $0.13 B |